BIOMAT Database Logo BIOMAT Database Logo

[Histamine-like compounds with cyclicized side chain. 1. Report on structure-activity relationships of histamine analogs]. 1973

W Schunack

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D010880 Piperidines A family of hexahydropyridines.
D003514 Cyclohexylamines A family of alicyclic hydrocarbons containing an amine group with the general formula R-C6H10NH2. Cyclohexylamine
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

W Schunack
Structure--activity relationships of side-chain modified didemnins.
January 2001, Bioorganic & medicinal chemistry letters,
W Schunack
Structure-activity relationships of clonidine- and tolazoline-like compounds at histamine and alpha-adrenoceptor sites.
August 1980, British journal of pharmacology,
W Schunack
Nicotinic pharmacology of anatoxin analogs. II. Side chain structure-activity relationships at neuronal nicotinic ligand binding sites.
October 1991, The Journal of pharmacology and experimental therapeutics,
W Schunack
Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites.
October 1991, The Journal of pharmacology and experimental therapeutics,
W Schunack
Structure-activity relationships in 1,4-benzodioxan-related compounds. 5. Effects of modification of the side chain on alpha-adrenoreceptor blocking activity.
January 1996, Farmaco (Societa chimica italiana : 1989),
W Schunack
Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
November 1983, The Journal of pharmacology and experimental therapeutics,
W Schunack
Structure--activity relationships of pyrrole amidine antiviral antibiotics. 1. Modifications of the alkylamidine side chain.
November 1979, Journal of medicinal chemistry,
W Schunack
Felodipine analogs: structure-activity relationships.
January 1987, Journal of cardiovascular pharmacology,
W Schunack
Structure-activity relationships of cadeguomycin analogs.
June 1991, The Journal of antibiotics,
W Schunack
Structure activity relationships of thyroxine analogs.
January 1976, Pharmacology & therapeutics. Part B: General & systematic pharmacology,
Copied contents to your clipboard!